Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer
- Dr. Bedrosian brings to Amylyx nearly 30 years of leadership in clinical research, development, and advancing pipeline programs into commercialized global products including as CMO at Ultragenyx,...
Source: marketscreener.com